Revolution Medicines Inc.

RVMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$194.82

+$2.06 (+1.07%)

Sep 22, 2026, 11:11 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ASND Ascendis Pharma A/S	N/A
BBIO BridgeBio Pharma	N/A
BMRN BioMarin Pharmaceutical	N/A
EXEL Exelixis	N/A
IONS Ionis Pharmaceuticals	N/A
MDGL Madrigal Pharmaceuticals	N/A
MRNA Moderna	N/A
RNA Atrium Therapeutics	N/A
ROIV Roivant Sciences	N/A
SMMT Summit Therapeutics	N/A

Dividend Rankings ➞

Recent News

2 days ago / defenseworld.net
Alan Sandler Sells 341 Shares of Revolution Medicines (NASDAQ:RVMD) Stock
2 days ago / defenseworld.net
Jack Anders Sells 4,053 Shares of Revolution Medicines (NASDAQ:RVMD) Stock
5 days ago / fool.com
Revolution Medicines Just Hit a Major Milestone. Is the Stock a Buy?
7 days ago / defenseworld.net
Concurrent Investment Advisors LLC Invests $475,000 in Revolution Medicines, Inc. $RVMD
8 days ago / globenewswire.com
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
12 days ago / defenseworld.net
Revolution Medicines, Inc. $RVMD Shares Bought by Arizona State Retirement System
18 days ago / marketbeat.com
Revolution Medicines Got Its Breakthrough—What Moves It Next?
18 days ago / zacks.com
Revolution Medicines (RVMD) Up 6.6% Since Last Earnings Report: Can It Continue?
25 days ago / marketbeat.com
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer
25 days ago / fool.com
Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales.